AdaptHealth Corp. (AHCO) stock soared 23.04% in Tuesday's pre-market trading session, driven by the company's impressive fourth-quarter 2024 financial results and positive outlook for 2025.
The medical equipment and services provider reported better-than-expected Q4 earnings, with net revenue of $856.65 million, beating the analyst consensus estimate of $829.19 million. AdaptHealth's net income of $51.4 million and earnings per share of $0.34 also exceeded Wall Street expectations, reflecting strong demand for the company's products and services.
The strong financial performance was backed by AdaptHealth's strategic initiatives, such as its "One Adapt" program aimed at enhancing operational efficiency and increasing clinical relevance. The company's focus on accelerating the application of AI and automation also contributed to its positive results.
Looking ahead, AdaptHealth provided an optimistic outlook for fiscal 2025, forecasting net revenue in the range of $3.22 billion to $3.36 billion, surpassing analysts' estimates of $3.33 billion. The company also expects to generate Adjusted EBITDA between $670 million and $710 million, and free cash flow ranging from $180 million to $220 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。